StockNews.AISignal intelligence

Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

Browse signals
UTHRBullishAnalyst Target Updateanalyst
Medium materiality5/10

United Therapeutics price target raised to $717 from $685

Oct 20, 2026, 11:22 AM EDT1 sourcesAI-analyzed
Why it may matterVerify against the original reporting

A modest target increase and substantial stated-price gap are supportive, though this remains an analyst opinion rather than a company catalyst.

AI summary

What happened, with direct paths to the underlying reporting

Raymond James raised its UTHR target from $685 to $717. The posted price was $564.15, leaving the new target substantially above it.

  • Target raised about 4.7%, to $717 from $685.
  • Posted price: $564.15; the target implies roughly 27% upside.

Key facts

  1. 01

    Target: $717

  2. 02

    Posted price: $564.15

  3. 03

    Analyst firm: Raymond James

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.

Related signals

More source-backed signals connected by company or event